Option chain shows key data for Galapagos's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Galapagos.

Galapagos (OTC:GLPGF) Stock, Option Chain

Galapagos NV is a fully integrated biotechnology company focused on discovering, developing, and commercializing medicines. The company is committed to improving patients' lives world-wide by targeting diseases with high unmet needs. Its R&D capabilities cover multiple drug modalities, including small molecules and cell therapies. Its portfolio comprises discovery through to commercialized programs in immunology, oncology, and other indications. Its first medicine for rheumatoid arthritis and ulcerative colitis is available in Europe and Japan. It derives maximum revenue from United States of America.

Biotech

News

Health Care

General

GLPG

GLPGF

Galapagos&#39; Filgotinib Shows Clinical Benefit In Ulcerative Colitis Non-Responding Patients

Contracts

Movers

Trading Ideas

GILD

Galapagos Assumes Responsibility Of Late-Stage Filgotinib Trial In Crohn&#39;s Disease

Management

Galapagos&#39; Long-Serving CEO Onno Van De Stolpe To Exit After R&amp;D Setbacks

Galapagos NV

Galapagos

Comments

Galapagos

Galapagos (GLPGF) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga